GlaxoSmithKline now faces a lawsuit alleging that an infant who was born with a heart defect because his mother took Paxil during the first trimester of her pregnancy is entitled to damages from GlaxoSmithKline. This lawsuit is consistent with the fat that the FDA has recently upped the warning from a category C to a category D, warning pregnant mothers that taking Paxil more than doubles the risk of a heart defect in babies. http://www.marketwatch.com